ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

19,587Medicare Part D Prescriptions Filled, Including Refills

Rank: 30 out of 1111

$1.1M Total Retail Price of All Prescriptions

Rank: 30 out of 1111

749 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
71% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Oklahoma
Lower avg

Schedule Two
Controlled Substances

7% of this provider’s 749 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

19% of this provider’s 749 patients filled at least one prescription for a schedule three drug, compared to an average of 18%.

Risky Drugs to Seniors

2% of this provider’s 14,625 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

25% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$56 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Oklahoma
LISINOPRIL 995 742 1 2
HYDROCODONE-ACETAMINOPHEN 734 507 S3 2 1
OMEPRAZOLE 644 477 3 4
SIMVASTATIN 612 516 4 5
AMLODIPINE BESYLATE 514 442 5 7
LEVOTHYROXINE SODIUM 471 419 6 3
GABAPENTIN 428 291 7 10
METFORMIN HCL 428 305 7 8
PRAVASTATIN SODIUM 405 287 9 17
FUROSEMIDE 400 320 10 6
HYDROCHLOROTHIAZIDE 362 271 11 11
CITALOPRAM HBR 347 272 12 14
ATORVASTATIN CALCIUM 342 287 13 15
METOPROLOL SUCCINATE 319 279 14 20
POTASSIUM CHLORIDE 315 257 15 9
NEXIUM 296 152 16 26
LISINOPRIL-HYDROCHLOROTHIAZIDE 270 218 17 23
SERTRALINE HCL 270 186 17 24
METOPROLOL TARTRATE 269 236 19 12
CARVEDILOL 237 174 20 21
GLIMEPIRIDE 237 160 20 61
PROAIR HFA 228 139 22 38
WARFARIN SODIUM 217 181 23 19
TRAMADOL HCL 183 119 24 13
RANITIDINE HCL 169 132 25 29
ZOLPIDEM TARTRATE 169 117 25 16
SPIRIVA 168 101 27 53
CYMBALTA 165 136 28 40
DONEPEZIL HCL 163 161 29 25
CLOPIDOGREL 151 128 30 30
CYCLOBENZAPRINE HCL 150 38 R 31 37
LIPITOR 148 131 32 116
DIOVAN 147 130 33 51
ALLOPURINOL 146 122 34 36
FLUTICASONE PROPIONATE 142 93 35 27
MELOXICAM 135 105 36 18
LOSARTAN POTASSIUM 134 111 37 34
NAMENDA 130 117 38 31
ATENOLOL 125 95 39 22
CRESTOR 117 38 40 33
PLAVIX 112 88 41 49
ADVAIR DISKUS 108 62 42 43
TRAZODONE HCL 105 59 43 32
POLYETHYLENE GLYCOL 3350 103 80 44 45
JANUVIA 101 58 45 75
ISOSORBIDE MONONITRATE ER 99 82 46 73
ALENDRONATE SODIUM 98 97 47 35
RISPERIDONE 98 90 47 60
PANTOPRAZOLE SODIUM 96 71 49 50
FLUOXETINE HCL 95 34 50 44
ROPINIROLE HCL 92 69 51 68
LANTUS 92 69 51 46
ZETIA 91 66 53 109
FENOFIBRATE 90 72 54 95
DIGOXIN 89 76 55 47
MUPIROCIN 88 67 56 154
NOVOLOG 87 83 57 104
MIRTAZAPINE 86 82 58 52
VENTOLIN HFA 82 38 59 122
SPIRONOLACTONE 77 74 60 83
OXYBUTYNIN CHLORIDE 76 69 61 110
SYMBICORT 76 55 61 176
AZITHROMYCIN 74 60 63 39
ENALAPRIL MALEATE 72 72 64 56
FAMOTIDINE 72 66 64 77
CLOTRIMAZOLE-BETAMETHASONE 71 70 66 194
TRICOR 70 50 67 157
LYRICA 68 51 68 62
LOSARTAN-HYDROCHLOROTHIAZIDE 68 57 68 72
GLYBURIDE 62 53 R 70 59
SULFAMETHOXAZOLE-TRIMETHOPRIM 62 46 70 71
VERAPAMIL ER 60 34 72 100
METOCLOPRAMIDE HCL 60 37 72 130
KLOR-CON M10 59 58 74 144
ESTRADIOL 54 24 R 75 102
CLONIDINE HCL 54 36 75 42
PROMETHAZINE HCL 54 28 R 75 69
GLIPIZIDE 54 37 75 57
PAROXETINE HCL 54 36 75 55
LANTUS SOLOSTAR 53 37 80 135
TIZANIDINE HCL 52 29 81 91
OLANZAPINE 52 35 81 117
TAMSULOSIN HCL 52 43 81 28
PHENYTOIN SODIUM EXTENDED 51 21 84 126
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 16, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.